Senores Pharmaceuticals Ltd

BSE :544319 NSE :SENORES Sector : Pharmac..
515.75
Change: 3.00(0.59%)
52 week Low
435.25
52 week High
644.80
Day low
492.95
Day high
530.25
Prev Close
512.75
Open
505.00
6M return
-7.41%
1Y return
-7.41%
MCap(Rs. in Cr.)
2,361.40
Total Volume
5,66,443
Face Value : 10
Listed Since 30 Dec 2024
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
0
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
0
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
0
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


No data available
No data available


Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Senores Pharma.
515.75
Change: 3.00 (0.59%)
1 Year return
-7.41%
Risk (Std Dev)
0.00%
PE Ratio
75.13889
MCap( in Cr.)
2,361.40
Emcure Pharma
996.05
Change: 996.05 (0.00%)
1 Year return
0.00%
Risk (Std Dev)
-
PE Ratio
30.79489
MCap( in Cr.)
18,669.46
Sai Life
670.40
Change: -0.90 (-0.13%)
1 Year return
-12.33%
Risk (Std Dev)
0.00%
PE Ratio
101.19155
MCap( in Cr.)
13,962.34
Blue Jet Health
788.25
Change: 36.35 (4.83%)
1 Year return
127.26%
Risk (Std Dev)
0.10%
PE Ratio
55.55
MCap( in Cr.)
13,042.87
Sanofi Consumer
4,739.85
Change: 35.90 (0.76%)
1 Year return
-3.34%
Risk (Std Dev)
0.03%
PE Ratio
NM
MCap( in Cr.)
10,833.49
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 0 with a of 0%

News

Stay tuned to the latest developments and happenings in the company.

Senores Pharmaceuticals consolidated net profit rises 141.97% in the December 2024 quarter

Net profit of Senores Pharmaceuticals rose 141.97% to Rs 17.18 crore in the quarter ended December 2024 as against Rs 7.10 crore during the previous q....

23 Jan 2025 14:48

Senores Pharmaceuticals to conduct board meeting

Senores Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 23 January 2025.Powered by Capital Market - Live....

11 Jan 2025 10:25

Senores Pharmaceuticals receives USFDA approval for Metoprolol Tartrate and Hydrochlorothiazide Tablet

Senores Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for marketing Metoprolol Tartrate a....

10 Jan 2025 10:23

View More
Subscribe for our
newsletter
Open Account Now